News
UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response
Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.